CareDx Director William A Hagstrom Sells Shares

Summary

William A. Hagstrom, a director at CareDx, sold 30,000 shares of the company’s common stock on May 28, 2025, at a weighted average price of $17.4471, totaling $523,412. After the transaction, Hagstrom holds 53,979 shares of CareDx directly.TradingView

Impact Analysis

This event is at the company level as it pertains specifically to an insider transaction involving CareDx. The sale of shares by a director can be interpreted in several ways. It might suggest the director’s expectations regarding future performance, personal liquidity needs, or changes in portfolio strategy. Historically, insider selling can sometimes be perceived negatively by the market if investors speculate that insiders are less optimistic about the company’s future prospects. Supporting this, recent news indicates that another director, Christine Cournoyer, has also reported the disposal of common stock.Reuters+ 2 Additionally, CareDx is participating in industry conferences and is subject to analyst ratings, with mixed sentiments which include a ‘neutral’ rating with a $25 target price and a ‘buy’ rating with a lowered target price of $26, down from $34.Market Beat+ 2 These ratings suggest market uncertainty or reevaluation of the company’s valuation. For investors, this insider sale could prompt a closer look at CareDx’s strategic direction and operational performance to assess the potential downside risk or identify any unjustified market reactions as buying opportunities.